Vasorelaxant effect of isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate, a novel metabolite from Salvia miltiorrhiza, on isolated rat mesenteric artery

被引:37
|
作者
Wang, Sheng-Peng [1 ]
Zang, Wei-Jin [1 ]
Kong, Shan-Shan [1 ]
Yu, Xiao-Jiang [1 ]
Sun, Lei [1 ]
Zhao, Xin-Feng [2 ]
Wang, Shi-Xiang [2 ]
Zheng, Xiao-Hui [2 ,3 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Div Cardiovasc Physiol & Pharmacol,Dept Pharmacol, Key Lab Environm & Genes Related Dis Minist Educ, Xian 710061, Peoples R China
[2] Xi An Jiao Tong Univ, Engn & Res Ctr Chinese Herb Modernizat, Xian 710061, Peoples R China
[3] NW Univ Xian, Inst Sci Anal, Shaanxi Prov Key Lab Electroanalyt Chem, Xian 710069, Peoples R China
关键词
isopropyl 3-(3; 4-dihydroxyphenyl)-2-hydroxypropanoate; Salvia miltiorrhiza metabolite; mesenteric artery; vasorelaxationl; calcium channel; potassium channel;
D O I
10.1016/j.ejphar.2007.10.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was designed to investigate the relaxant effect of isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate (IDHP), a new metabolite from Salvia miltiorrhiza, on rat mesenteric artery. Isolated mesenteric arterial rings were mounted in organ baths and the isometric tension changes were measured continuously by a sensitive myograph system. The results showed that IDHP at concentrations greater than 0.1 nM produced a concentration-dependent relaxation of artery contracted by norepinephrine with pEC(50) of 7.41 +/- 0.08. Removal of the endothelium did not affect this relaxation, suggesting that IDHP exerted a direct effect on vascular smooth muscle cells. Meanwhile, the vasorelaxant effect of IDHP was unaffected by pre-treatment with ATP-sensitive K+ channel inhibitor glibenclamide, delayed rectifier K+ channel inhibitor 4-aminopyridine, inwardly rectifying K+ channel inhibitor barium chloride and beta-adrenoceptor antagonist propranolol. However, the non-specific K+ channel inhibitor tetraethylammonium (TEA, 3 mM) produced a rightward shift of 1.8 fold on the concentration-response curve of IDHP. Moreover, IDHP shifted the concentration-response curve of CaCl2 as well as two receptor-mediated constrictors, phenylephrine and 5-hydroxytryptamine, to the right in a non-parallel manner. In the absence of extracellular Ca2+, IDHP depressed the contractions induced by norepinephrine and CaCl2, and the maximal inhibitions were 48.3 +/- 18.9% and 58.4 +/- 10.9%, respectively. These results suggest that IDHP exerts a vasorelaxant effect by inhibiting both Ca2+ release from intracellular stores and Ca2+ influx through voltage-dependent calcium channels, and receptor-operated calcium channels in vascular smooth muscle cells. In addition, activation of vascular TEA-sensitive K+ channels may be partially involved in the relaxant effect of IDHP. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 30 条
  • [1] Analysis of Isopropyl 3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoate, a Metabolite of Danshensu, from Salvia miltiorrhiza, in Rabbit Plasma
    Qunzheng Zhang
    Zhongjin Li
    Xinfeng Zhao
    Shixiang Wang
    Xiaohui Zheng
    Chromatographia, 2008, 68 : 1067 - 1070
  • [2] Analysis of Isopropyl 3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoate, a Metabolite of Danshensu, from Salvia miltiorrhiza, in Rabbit Plasma
    Zhang, Qunzheng
    Li, Zhongjin
    Zhao, Xinfeng
    Wang, Shixiang
    Zheng, Xiaohui
    CHROMATOGRAPHIA, 2008, 68 (11-12) : 1067 - 1070
  • [3] Isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate
    Nan, Ye-Fei
    Zhang, Qun-Zheng
    Shen, Xu-Ji
    Zhao, Xin-Feng
    Zheng, Xiao-Hui
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1105 - U360
  • [4] Anti-Inflammatory Effects of Isopropyl 3-(3, 4-Dihydroxyphenyl)-2-Hydroxypropanoate, a Novel Metabolite from Danshen, on Activated Microglia
    Wang, Shaoxia
    Wang, Hong
    Jing, Haoran
    Wang, Shixiang
    Kang, Liyuan
    Gao, Xiumei
    Hu, Limin
    Zheng, Xiaohui
    CHINESE JOURNAL OF PHYSIOLOGY, 2012, 55 (06): : 428 - 434
  • [5] Isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate protects lipopolysaccharide-induced acute lung injury in mice by attenuating pyroptosis
    Zhang, Mei-Ling
    Wang, Meng
    Chen, Jian
    Liu, Yan-Jie
    Yu, Ya-Jie
    Liu, Li-Min
    Zheng, Xiao-Hui
    Xiao, Ying-Chou
    Zhang, Jun-Ming
    Zhu, Meng-Xue
    Yue, Xian
    Zhao, Ye
    Niu, Wen
    Li, Zhi-Chao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 942
  • [6] Isopropyl 3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoate Alleviates Palmitic Acid-Induced Vascular Aging in HUVEC Cells through ROS/Ferroptosis Pathway
    He, Xin
    Zheng, Xiaohui
    Xie, Weidong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [7] Isopropyl 3-(3,4-dihydroxyphenyl) 2-hydroxypropanoate protects septic myocardial injury via regulating GAS6/Axl-AMPK signaling pathway
    Lei, Wangrui
    Xu, Xuezeng
    Li, Ning
    Zhang, Yan
    Tang, Ran
    Li, Xiaoru
    Tang, Jiayou
    Wu, Xue
    Lu, Chenxi
    Bai, Yajun
    Yao, Yu
    Qiu, Zhenye
    Yang, Yang
    Zheng, Xiaohui
    BIOCHEMICAL PHARMACOLOGY, 2024, 221
  • [8] Efficient and practical asymmetric synthesis of isopropyl (R)-3-(3′,4′-dihydroxyphenyl)-2-hydroxypropanoate and its enantiomer
    Chen, Ming
    Chen, Hui
    Wang, Yuzhen
    Wang, Haibo
    Nan, Yefei
    Zheng, Xiaohui
    Jiang, Ru
    TETRAHEDRON-ASYMMETRY, 2011, 22 (01) : 4 - 7
  • [9] Isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate plays an anti-hypoxic role through regulating neuroactive ligand-receptor interaction signaling pathway in larval zebrafish
    Zhang, Siyue
    Wang, Xixin
    Yang, Qing
    Xia, Qing
    Zhao, Ye
    Zheng, Xiaohui
    Zhang, Yun
    Liu, Kechun
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [10] Isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate protects lipopolysaccharide-induced acute lung injury in mice by attenuating pyroptosis (vol 5, 175545, 2023)
    Zhang, Mei-Ling
    Wang, Meng
    Chen, Jian
    Liu, Yan-Jie
    Yu, Ya-Jie
    Liu, Li-Min
    Zheng, Xiao-Hui
    Xiao, Ying-Chou
    Zhang, Jun-Ming
    Zhu, Meng-Xue
    Yue, Xian
    Zhao, Ye
    Niu, Wen
    Li, Zhi-Chao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 990